Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anagrelide in Japanese adults with essential thrombocythemia
NCT01214915Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2010
- Primary completion
- Oct 2012
- Countries
- 1
01
Overview
A Phase 3 trial of anagrelide in essential thrombocythemia (ET), sponsored by Takeda. Started Oct 2010; status: completed.
02
Drugs
anagrelide
03
Conditions
essential thrombocythemia (ET)
Beyond the preview
Go deeper on NCT01214915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214915.